Mayo Clinic

13F Portfolio Filings

Latest 13F report
Q2 2024 - Aug 12, 2024
Value $
$3.03M
Signature - Title
Paul Gorman - Chief Investment Officer
Location
200 First Street Sw, Rochester, MN
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q2 2024 4 $3.03M $0 -$862K -$862K ACWI, ZNTL, UBX, NMTC 13F-HR 8/12/2024, 08:00 AM
Q1 2024 5 $6.15M +$862K -$11.9M -$11M ZNTL, ACWI, CATX, NMTC, UBX 13F-HR 5/13/2024, 09:30 AM
Q4 2023 7 $16.2M +$1.17M -$40.6M -$39.4M ACWI, ZNTL, IMNM, NMTC, UBX 13F-HR 2/13/2024, 12:12 PM
Q3 2023 9 $51.9M $0 -$41.4M -$41.4M ACWI, ZNTL, BSM, UBX, MIRO 13F-HR 11/14/2023, 09:14 AM
Q2 2023 11 $97.4M $0 -$34.9M -$34.9M ACWI, BSM, ZNTL, MIRO, UBX 13F-HR 8/9/2023, 02:55 PM
Q1 2023 13 $122M +$705K -$77.8M -$77.1M ACWI, BSM, ZNTL, EXAS, SCLX 13F-HR 5/5/2023, 09:00 AM
Q4 2022 13 $189M $0 $0 ACWI, BSM, ZNTL, EVLO, MIRO Restatement 2/9/2023, 01:15 PM
Q2 2021 9 $1.21K $0 $0 NMTC 13F-HR 8/12/2021, 04:06 PM
Q1 2021 8 $86.9M +$120K -$6.71M -$6.59M BSM, ZNTL, UBX, SRNE, EVLO 13F-HR 5/13/2021, 10:13 AM
Q4 2020 9 $83.1M +$4.49M -$184 +$4.49M BSM, ZNTL, UBX, SPY, EVLO 13F-HR 2/11/2021, 11:56 AM
Q3 2020 9 $184 $0 $0 CGIX 13F-HR 11/12/2020, 10:41 AM
Q2 2020 9 $105M +$49.2M -$553K +$48.7M BSM, SPY, ZNTL, UBX, EVLO 13F-HR 8/13/2020, 12:27 PM
Q1 2020 8 $39.6M +$233K -$229K +$3.66K BSM, UBX, EVLO, BSGM, MCRB 13F-HR 4/24/2020, 11:09 AM
Q4 2019 8 $88.2M $0 $0 BSM, UBX, EVLO, BSGM, MCRB Restatement 2/18/2020, 05:11 PM